| abstract |
The present invention relates to a substantially pure amorphous lercanidipine hydrochloride which is at least 95% pure, preferably at least about 97% pure, even more preferably at least about 99% pure, and most preferably at least about 99% pure ,5 %. The invention also relates to methods for producing substantially pure amorphous lercanidipine and pharmaceutical compositions that contain substantially pure amorphous lercanidipine. |